Insider trades

Salomon Azoulay, Chief Officer of MBX Biosciences MBX, has filed 0 purchases and 3 sales on the open market. Over the past 12 months that comes to a net sale of $2.7M. The latest trade was on 05/08.

Salomon Azoulay

Chief Medical Officer
First filing
24/09/13
Trades
11 trades
Buys / sales
0 / 3
12-month net buying
−$2.7M
Last trade
05/08

Trading activity

Transactions

Trade type
MBX
Open-market sale10b5-1 plan05/0805/1170,003 sh2 trades$38.36avg.$2,685,514.9−82.6%
Open-market sale05/0605/08231 sh$29.54$6,823.74−1.5%